According to a source, Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin.
The three-dose DNA built vaccine has 66.6 per cent efficacy against Covid.
As part of the nationwide vaccination drive, the government has been supporting states and UTs by providing them COVID-19 vaccines for free, the ministry said.
As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them COVID-19 vaccines free of cost.
The Odisha government has released a set of guidelines for the launch of a special Covid vaccination campaign for teachers and non-teaching staff of schools across the State.
A possible third wave of coronavirus infection can hit its peak between October-November if Covid-appropriate behaviour is not followed, but it may see half the daily cases recorded during the second surge, said a scientist of a government panel tasked with modelling of COVID-19 cases.
"From then on, we should be able to vaccinate everybody in India properly and that should help us," he said, amid a shortage of vaccine in various states.
Biological-E's vaccine is currently in Phase-3 clinical trials after showing promising results in Phase 1 and 2, and it is likely to be available in the market in next few months, said a Ministry of Health and Family Welfare (MoHFW) statement.
Odisha CM Naveen Patnaik said though many states have floated global tenders for vaccine procurement, the global vaccine manufacturers are looking forward to the Union Government for the clearances and assurances.
For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators, and state and Central government agencies, it added.
The new antiviral approach used gene-silencing RNA technology called siRNA (small-interfering RNA) to attack the virus' genome directly, which stops the virus from replicating, as well as lipid nanoparticles designed at Griffith University and City of Hope to deliver the siRNA to the lungs, the critical site of infection.
Mixing Covid-19 vaccine doses -- second dose from a different brand than the first -- is safe, but may present more frequent mild side-effects such as a headache, chills or a fever, showed results of a preliminary study published in the Lancet.
London: The UK government has donated 20 million pounds ($26 million) towards a break-neck plan to produce a vaccine to combat the deadly new coronavirus, which has till Monday claimed the lives of 361 people in China alone. On Sunday, Health Secretary Matt Hancock said that government’s investment will go to CEPI – the Coalition […]
New Delhi: A scientist involved in developing a coronavirus vaccine at Australia’s University of Queensland has said that it may take about one year before people will actually be able to use it. The Coalition for Epidemic Preparedness Innovations (CEPI), a partnership against epidemics by public, private, philanthropic, and civil organisations earlier commissioned the University […]
Sydney: A team of researchers at the University of Queensland in Australia has created their first vaccine candidate in the laboratory for the novel coronavirus, COVID-19. The team will move immediately into further development before formal pre-clinical testing, the university said on Friday. The proof-of-concept milestone comes in less than a month after the project’s […]
LIVE TV
